Recent study reveals KGM’s benefits on glucose, lipid metabolism, and gut microbiota in obese mice, with potential applications for human metabolic health. New research highlights konjac glucoma...
New research reveals konjac glucomannan’s unique ability to modulate gut microbiota and improve metabolic markers through different intake forms, offering novel obesity management strategies. Cu...
New research reveals konjac glucomannan’s unique ability to combat obesity through mechanical and biochemical mechanisms, with frozen gel form showing 18% greater efficacy in mice studies. Cutti...
New research reveals prenatal PFAS exposure may impair maternal beta cell function long-term, increasing diabetes risk amid widespread contamination concerns. Groundbreaking study connects prenatal PF...
New research highlights konjac glucomannan’s potential in weight management and metabolic health through gut microbiota modulation and SCFA production. Recent studies demonstrate konjac glucoman...
New research reveals KGM sol reduces insulin resistance 40% and boosts GLP-1 2.1-fold in obese mice, with emerging clinical evidence supporting human applications. Groundbreaking mouse studies demonst...
New research reveals how modified forms of konjac glucomannan differentially impact glucose and lipid metabolism in obesity through gut microbiota alterations. Cutting-edge studies demonstrate konjac ...
Recent research reveals how intermittent fasting protocols interact with circadian rhythms to improve insulin sensitivity, gut microbiome diversity, and metabolic markers beyond weight loss. Emerging ...
A 12-week clinical trial explores time-restricted eating’s potential to enhance mitochondrial function and reduce oxidative stress in early-stage Huntington’s disease. A new clinical trial inv...
Recent studies demonstrate konjac glucomannan’s effectiveness in improving glucose and lipid metabolism, with novel gel forms showing enhanced benefits for obese individuals. Emerging research r...
